skip to Main Content

Effects of Osteopathic Manipulative Treatment (OMT) on Gait Biomechanics in Parkinson’s Disease (OMT/PD)


Brief Summary:

Parkinson’s disease (PD) is a neurological disorder that puts individuals at high risk for
injuries and long-term disabilities as a result of a fall or other trauma. Injuries sustained
from falls account for many deaths as well as thousands of hospital admissions and nursing
home stays every month. Quality of life and even longevity itself is reduced due to the
resulting surgeries, immobility, complications and even cognitive impairments that can
follow. The proposed study will explore beneficial impact of a treatment modality (OMM/OMT)
that may significantly reduce the morbidity of this condition by comparing 6 weeks of OMT
versus 6 weeks light touch intervention versus 6 weeks care as usual to improve gait in
individuals with PD. Gait will be measured at mid-treatment, post-treatment and 4-week


Inclusion Criteria:

1. Age > 18 years.

2. Ambulatory without use of assistive device.

3. Fluency in written and spoken English.

4. Montreal Cognitive Assessment (MoCA) score > or = 17.

5. Stages 1 – 4 Parkinson’s Disease diagnosis as measured by the Unified Parkinson’s
disease rating scale.

Exclusion Criteria:

1. Currently enrolled in another clinical trial.

2. Current taking PD medications co-morbid conditions such as pseudobulbar palsy or
amyotrophic lateral sclerosis which may have musculoskeletal effects.

3. Individuals with current fractures, tumors, wounds.

4. Any lifetime Deep Brain Stimulation implant surgery.

5. Recent surgeries, eg., within past 90 days.

6. Patients who have experienced hospitalization due to a fall within the past 12 months.

7. Gait abnormalities other than Parkinson’s disease.

8. Received OMT or another forms of manipulative therapy within the past two months.

9. Stage 5 Parkinson’s Disease diagnosis per as measured by the Unified Parkinson’s
disease rating scale.

10. Other co-morbid conditions that in the opinion of the PI would interfere with
participation in this study.

11. Diagnosis of psychosis or dementia (MoCA, DRS or other indication in eMR).

12. Pregnancy


  • University of California, San Diego, La Jolla, California, United States, 92093
Back To Top